Patrick O'Shaughnessy

“How would you characterize the general health of the private credit space right now in light of some of the growing concerns about credit quality? And then what's the read-through in terms of your sales pipeline?”

“Curious about your thoughts on how CME's introduction of single-stock futures might impact the equity options world.”

“I was hoping you could provide a little bit more detail on the 6% internal growth within ICS this quarter. Were there tailwinds besides the equity revenue position count growth that you called out?”

“Curious if you're seeing any evidence of commission compression in sales or leasing or things remain pretty stable on that front.”

“So you mentioned likely ramping up your share repurchase activity in the back half of the year, but you also spoke to a healthy M&A pipeline. How are you thinking about balancing the ramping up or repurchases versus keeping powder dry for M&A?”